Company Analysis

Celldex Therapeutics, Inc. (CLDX)

Nasdaq: CLDX · In Vitro & In Vivo Diagnostic Substances · Hampton, NJ · filing with the SEC since 1995
Grade5.1
◀ Past 3.8● Present 6.0▶ Future 5.1
1 est.

Who runs Celldex Therapeutics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Marucci Anthony S
PRESIDENT & CEO. First filing Mar 2008, latest Jun 29, 2026, 3 filings in all.
Officers reporting now
11
of 19 people with a filing in the last fifteen months
Directors reporting now
8
27 people on the record since 2006
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Marucci Anthony SPRESIDENT & CEOMar 2008Jun 29, 2026none
Martin Samuel BatesSVP AND CFOJul 2017Jun 29, 2026none
Lawver Teri LSVP & Chief Commercial OfficerNov 2025Jun 29, 2026none
Young Diane C.SVP, CHIEF MEDICAL OFFICERJul 2019Jun 29, 2026none
Cavanaugh SarahSVP OF CORP AFFAIRS & ADMIN.Jun 2017Jun 29, 2026none
Crowley ElizabethSR. VP & CPDOAug 2016Jun 29, 2026none
Heath-Chiozzi MargoSVP OF REGULATORY AFFAIRSOct 2017Jun 29, 2026none
Jimenez Freddy A.SVP & GENERAL COUNSELJan 2021Jun 29, 20261 · $100,000
Keler TiborEXECUTIVE VP & CSOMar 2008Jun 29, 2026none
Pepin RonaldSR. VP & CBOJul 2011Jun 29, 2026none
Wright Richard M.SR. VP & CCOJul 2015Nov 17, 20251 · $1.2M
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Brownlie Keith LdirectorJun 2017Jun 29, 2026none
Cohen CheryldirectorJun 2022Jun 29, 2026none
Conrad Herbert JdirectorMar 2008Jun 29, 2026none
Jain RitadirectorFeb 2023Jun 29, 2026none
Marino James JdirectorMar 2017Jun 29, 2026none
Neil Garry ArthurdirectorJun 2022Jun 29, 2026none
Penner Harry JrdirectorMay 2006Jun 29, 2026none
Torres DenicedirectorJun 2025Jun 29, 2026none
Earlier names on the record8, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CLDX · research, not advice